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1.  Introduction and Aim of the Study 
 
One of the most complex mechanisms in the human body is the regulation of signal 
transduction between nerve cells. As a workhorse in the termination of neurotransmission, the 
serotonin transporter (SERT), a member of the neurotransmitter sodium symporter (NSS) or 
solute carrier 6 family (SLC 6), responsible for the reuptake of serotonin out of the synaptic cleft 
back in the nerve cell. Though being quite selective for its natural ligand, the SERT is targeted by 
many antidepressants and illicit drugs in order to modify the signal and therefore generally 
achieve a mood lifting effect, but little is known about the molecular basics of the interaction 
both of the natural ligand and other substrates with the receptor protein. Especially challenging 
in studies of membrane-bound proteins is the fact that due to technical difficulties in the 
crystallizing process, X-ray structures and other high-resolution structural data are mostly 
unavailable, so potent computational methods such as homology modeling and docking are 
needed to determine molecular binding modes. 
In case of the serotonin transporter, the closest relative protein offering a crystal structure is a 
bacterial leucine transporter found in Aquifex aeolicus, very similar in structure and function. 
Taking it as a template, a homology model of its eukaryotic counterpart can be created. 
(Beuming et al. 2006) 
The aims of the study include the creation of a hSERT homology model on the basis of the LeuT, 
then to use it for Induced Fit docking with several ligands and the further evaluation of binding 
modes, if available, in comparison with already published data, to determine the predictive 
potency of the method. The results yielded by the experiments were expected to improve the 
knowledge about already established ligand binding modes, but also they should allow 
sufficiently reliable suggestions for yet unknown protein-ligand interaction patterns, being able 
to explore poses that were up to now inapproachable due to not considering the flexibility of 
the protein. 
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2.  Biology 
 
To understand the function of a protein, it is necessary to know the physiological system it 
belongs to. The following section should provide an insight to the biological background of 
neurotransmission in the human central nervous system, emphasizing the molecular level. 
 
2.1  Nerve Cells 
 
A typical mammalian nerve cell, independent of its further structural classification, consists of 
the soma, which is the cell body including the nucleus, the dendrites, responsible for the 
majority of information input, and the axon, transporting the signal to target neurons. This 
division in an incoming and an out-bound part explains the unidirectionality of nerve impulses, 
what is ensured by the fact that on the one hand dendrites have no possibility to secrete 
neurotransmitters and on the other hand no chemoreceptors are available on the terminal 
axon. 
 
2.2 Neurotransmission 
 
In most cases, the communication between nerve cells requires that neurons transform an 
electrical into a chemical signal in order to pass on incoming impulses. The arriving action 
potential leads to opening of potential-dependent Ca++-channels, causing exocytosis of vesicle-
stored neurotransmitters. This stimulated neurotransmitter release on the one hand and 
specific detection of the neurotransmitter by one or more contiguous – up to 15.000 - cells on 
the other hand is located at specialized junctions called synapses between the terminal axon 
and the acceptor dendrites. Therefore, orchestrated release and uptake of signal molecules are 
crucial to achieve orderly communication between neurons. (Gouaux 2009)  An incoming 
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impulse can immediately raise extracellular neurotransmitter concentrations by 105 fold. That 
leaves behind a challenging task for the adjacent cells to quickly re-establish pre-signal 
conditions which is necessary to ensure reasonable impulse intervals. Therefore, the removal of 
transmitters from the adjacencies of their receptors can be performed by three different 
mechanisms.  At first, the transmitter diffuses into the interstitial fluid, being diluted to 
inoperative concentrations. Second, some substances as ATP, acetylcholine or neuropeptides 
are directly enzymatically degraded in the synaptic cleft. The third mechanism is the specific 
uptake of the substances by membrane-bound transporter proteins to either the emitting 
presynaptic cell (reuptake) with the possibility of recycling them by anew vesicular storage, or 
into other surrounding cells, that lack of specific carriers and therefore just have the possibility 
of degradation. There are rather large differences between the vesicular, axolemma-situated 
and adjacent cell membrane-bound neurotransmitter transporters in driving force as well as in 
structure and pharmacology. For instance, vesicular uptake is granted by an in-place generated 
electrochemical proton gradient, whereas the reuptake through the axolemma is ensured by a 
sodium gradient between the extra- and intracellular side of the neuron. Acting as Na+-
neurotransmitter co-transporters, there are highly specific carriers for serotonin, dopamine, 
norepinephrine, glutamate, GABA and glycine. (Aktories et al. 2005) 
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Figure 1: Synaptic signal transduction, taken from Aktories et al., 2005 
 
 
2.2.1  Monoamine Transporters  
 
As mentioned before, monoamine transporters are the main instruments to clear the synaptic 
cleft of certain small-molecule neurotransmitters with a positively charged amino group. Below 
there is a scheme describing the main monoamine cycles, also showing some prominent drugs 
interacting with the respective transporter. 
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2.2.1.1 Localization 
 
All human monoamine transporters are members of the solute carrier 6 (SLC 6) family, but each 
one is localized on a different gene. NET (SLC6A2) spans 45 kb respectively 14 exons on 
chromosome 16q12.2, the DAT (SLC6A3) gene has a size of 65 kb spread over 15 exons on the 
5p15.3 chromosome, whereas the human SERT (SLC6A4) is divided into 13 exons on the 17q11 
chromosome, covering 24 kb. (Torres et al. 2003) 
The expression of monoamine transporters in the central nervous system is very tightly bound 
to neurons containing their substrate transmitter. Dopamine transporter (DAT) expression is 
prominent in the cell bodies of the substantia nigra and the ventral tegmentum, both located in 
the mesencephalon floor. In case of the noradrenaline transporter (NET), the area of interest is 
the locus coeruleus and several other nuclei in the brain stem, as serotonin transporters (SERT) 
can be found in the dorsal and median raphe nuclei. 
Figure: Scheme of monoamine-related synaptic terminals, taken from Torres, 2003 Figure 2: Scheme of monoamine-related synaptic terminals, modified from Torres, 2003 
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Figure 3: Serotonergic (green), dopaminergic (blue) and noradrenalinergic (red) nerve tracts, taken from Aktories 
et al., 2005 
 
2.2.2  SERT Structure and Function 
 
The monoamine transporters are essentially needed during the first step of transmitter 
recycling, so the transport itself has to be tightly regulated to avoid uncontrolled flux between 
nerve cell and the surrounding synaptic cleft. The unique structure of the SLC 6 protein family 
assures regulated transport by different key properties. First, the binding site is responsible for 
highly selective substrate binding. As the SERT is a co-transporter, also ion binding sites in the 
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correct relative position to the substrate binding site are critical for the transport. Second, 
accessing the binding site must not be possible from both sides of the membrane 
simultaneously to avoid uncoupled flux. Just the coupled binding of serotonin and Na+/Cl- 
allows the required conformational changes of the protein from the open-to-out state to the 
occluded state and finally the open-to-in configuration, where substrate and ions can be 
released. Subsequently, binding of a potassium ion initiates the return to the first state. (Gary 
Rudnick 2006)  
 
Figure 4: Possible mechanism of serotonin transport, taken from Rudnick, 2006 
 
After the structure determination of the LeuT by the group of Eric Gouaux in 2005 the highly 
resolved data granted insights to the topology of the substrate binding site of monoamine 
transporters. Two sodium ions bound together with leucine in the active site were identified. 
Comparing the residues involved in ion binding with the corresponding residues in SERT showed 
that most were identical or conservatively substituted, as for example two serines were 
replaced by threonines. The effect of presence or absence of the sodium ions has a different 
impact on the binding quality in SERT depending on the particular ligand. Serotonin, for 
instance, is not affected by missing sodium, but ß-CIT seems to need at least one sodium ion 
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coordinated by residues corresponding to those in LeuT. (Humphreys et al. 1994) To be on the 
safe side, two sodium ions were included during the modeling.  
2.2.3  Neurotransmitters 
 
Neurotransmitters are presynaptic released substances with influence on the following cell. 
They are members of four major chemical groups: Amines, amino acids, neuropeptides and 
nucleotides.  Very prominent examples of these neurotransmitters are biogenic amines such as 
5-hydroxytryptamine (serotonin), norepinephrine (noradrenaline) or dopamine. (Torres et al. 
2003) The importance of those small molecules is underlined by the fact that they are all closely 
related to proteinogenic amino acids, as they can be derived from them by decarboxylation and 
eventually one or more hydroxylation steps. (Fig. 1) They control various functions of the 
human body ranging from locomotion to hormone secretion, which requires precisely regulated 
signal duration and intensity.  
OH
NH
2
OH
O
OH
OH
NH
2 OH
OH
OH
NH
2
N
H
OH
O
NH
2 N
H
OH
NH
2
OH
NH
2
OH
O
OH
L-Tyrosine
Dopamine Norepinephrine
L-Tryptophan Serotonin
L-DOPA
Tyrosinehydroxylase DOPA decarboxylase
Dopamine ß-hydroxylase
Tryptophanhydroxylase
aromatic L-amino acid decarboxylase
 
Figure 5: Amino acids as neurotransmitter precursors 
All neurotransmitters except neuropeptides, that are built in ribosomes and delivered to the 
nerve ends by axonal transport, are locally synthesized out of precursor molecules and packed 
in the nerve ends. Vesicular storage not only holds ready well-defined doses of signal 
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molecules, but also prevents the freshly produced neurotransmitters from enzymatic 
degradation.  
3.  Pharmacology 
 
Many agents affecting the brain function including antidepressants, neurotoxins and 
psychostimulants target monoamine transporters. The mechanism of action depends on the 
drug, as cocaine acts as a competitive, non-selective inhibitor, and amphetamine-like 
substances achieve reverse transport of neurotransmitters, thus pumping them into the 
extracellular space instead of taking them up. Both result in high extracellular monoamine 
levels. For the studies carried out on the hSERT a set of seven compounds was used, as for 
some the interaction pattern with the target is quite well-defined and for some it is rather 
unknown.  
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Figure 6: Ligands used for the study 
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3.1  Serotonin 
 
The first used ligand was the natural substrate of the SERT, serotonin. The highest serotonin 
quantities in the human body can be found in the enterochromaffin gut cells of the 
gastrointestinal tract and in thrombocytes. Compared to them, neuronal serotonin levels are 
rather low; nevertheless serotonergic neurons are assumed to be responsible for the regulation 
of sleep patterns, mood, sensation of pain, ingestion and body temperature.  As mentioned 
earlier, the amino acid tryptophan is the precursor of serotonin. As it is an essential amino acid, 
the speed of the synthesis is limited by the supply of tryptophan. In the first step of 
biosynthesis, it is hydroxylated to 5-Hydroxytryptophan by the cytoplasmatic 
tryptophanhydroxylase. During the second step 5-Hydroxytryptophan is decarboxylated to 
serotonin by the aromatic L-amino acid decarboxylase, the same enzyme that is also involved in 
catecholamine synthesis. This also explains the usual abbreviation '5-HT' for serotonin, as the 
resulting decarboxylation product is 5-HydroxyTryptamin.  After the final step serotonin is 
transported to storage vesicles, waiting for its use. With the exception of 5-HT3 as the only 
ionotropic receptor, serotonin targets a variety of G protein coupled receptors activating 
intracellular second messenger cascades. After reuptake, serotonin is either stored in the also 
partially recycled vesicles or degraded to 5-Hydroxyindolacetaldehyd by monoamine oxidases 
with the subtypes MAO-A and MAO-B, being further metabolized to 5-Hydroxyindoleacetic acid 
(5-HIAA) as the main metabolite in the urine. Serotonin and its metabolites can also be 
conjugated with sulphuric or glucuronic acid, partially already in the central nervous system. 
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Figure 7: Serotonin pathway 
 
3.2  MDMA 
 
3,4-Methylenedioxymethamphetamine ('Ecstasy') is a semi-synthetic hallucinogen with high 
structural similarity to amphetamine. It was first synthesized and patented by Merck 
Pharmaceuticals in 1914. Precursor compounds can be found in plants like nutmeg, saffron and 
vanilla beans. (Lyles & Cadet 2003) Its action on the serotonergic system depends on the block 
of 5-HT reuptake and induction of 5-HT release, whereas a variety of other targets is also 
affected. Producing euphoria and mild stimulation, its use as a recreational drug in Europe and 
North America is increasingly popular among young people. Though often described as a 
relatively harmless drug, acute toxic side effects like malignant hyperthermia, hepatitis and 
convulsions can occur. In addition, long-term use of MDMA is strongly associated with 
neurotoxic effects observed at frequent consumers, including selective degeneration of 
serotonergic axons (White et al. 1996)  
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Figure 8: Comparison of Amphetamine and MDMA 
The precise role of MDMA in the process of destroying brain serotonin terminals is still unclear, 
but recent studies also suggest the involvement of metabolites like 3,4-
methylenedioxyamphetamine (MDA). There are two main pathways in MDMA metabolism. The 
first pathway leads via O-demethylenation to 3,4-dihydroxymethamphetamine (HHMA) and 
further O-methylation to 4-hydroxy-3-methoxymethamphetamine (HMMA), and is followed by 
subsequent conjugation with glucuronic acid or sulfate. The second pathway starts with N-
demethylation to MDA and ends up in corresponding glycine-conjugated benzoic acid 
derivatives formed by several desamination and oxidation steps. (Mueller et al. 2009) 
 
Figure 9: MDMA metabolites, taken from Mueller et al., 2009 
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3.3  Methylphenidate 
 
This prominent ring-substituted amphetamine-like psychostimulant currently mainly used in 
attention-deficit/hyperactivity disorder (ADHD) and narcolepsy has a high inhibition potency for 
DAT and NET (Ki = 0.1 µM). Also a certain potency, even if much weaker, for SERT (Ki = 100 µM) 
can be observed. (Han & Gu 2006) The potency in blocking DAT is as high as the one of cocaine, 
with less side effects. (N D Volkow et al. 1999) Despite the low SERT affinity it was chosen for 
interaction studies in that protein, both to see if a noteworthy difference to high-affinity ligands 
is being reflected in the number of docking poses retrieved and calculated binding energy. Also, 
at least in knock-out mice a mentionable effect of methylphenidate 6on the SERT has strongly 
been suggested, hence being subject of discussion. (R R Gainetdinov & M G Caron 2001) 
 
NH
2
CH
3
N
H
OO
amphetamine
methylphenidate  
Figure 10: Amphetamine - methylphenidate relationship 
 
The cyclic structure of methylphenidate causes the formation of two chiral centers in 2 and 2' 
position, but experiments have shown that the R,R-(+)-threo configuration of the molecule is 
far more potent than the S,S-(–)-threo enantiomer. (Aoyama et al. 1996)  Degradation is 90% 
done by hepatic cytochromes, leading to oxidized metabolites like ritalinic acid, hydroxy- and 
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oxymethylphenidate, less than 1% are excreted unmodified with the urine.  The main 
metabolite, ritalinic acid, was also supposed to possess pharmacological activity, but later 
studies led to the assumption that it does not seem to have important activity contributions. 
(Yu-Shin Ding et al. 2004) 
 
3.4  Cocaine 
 
The illegal status of the tropane alkaloid originates from its psychotropic and highly addictive 
potential.  Despite this, the drug itself is a potent inhibitor of all monoamine reuptake 
transporters, making it highly interesting for this study. The substance extracted from leaves of 
Erythroxylum coca was primarily used as stimulant among South American natives. The original 
use of cocaine in the western world as a local anesthetic today is very limited due to potential 
cardiotoxicity and its high vasoconstrictor activity, which yet can be desirable during surgery to 
avoid bleeding, but derivatives with a more favorable side effect profile outstripped it almost 
entirely. (Kovacic 2005) Apart from that, the importance of cocaine as a drug of abuse is 
enormous. Nearly any route of administration can be considered for cocaine abuse, whereas 
the major ones are intranasal, intravenous and through smoking. This is followed by a6 rapid 
metabolism by various liver enzymes, whereas the main metabolite benzoylecgonine is formed 
by a nonspecific liver carboxylesterase, also responsible for the formation of coca ethylene in 
the presence of ethanol, both metabolites being important for toxicological screening and 
quantification procedures. (Brzezinski et al. 1994) Also, cytochrome P-450 enzymes are involved 
in cocaine metabolism, as the 3A4 subtype acts as cocaine N-demethylase resulting in 
norcocaine, followed by several other CYP subfamily related metabolism steps. (Pellinen et al. 
2000) 
 
3.5  Benzatropine 
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Being a cocaine-like tropane alkaloid, Benzatropine is also an inhibitor of monoamine 
transporters, yet showing higher DAT specificity, which was the reason to take it as a lead 
compound for even more DAT-selective drugs. (Rothman et al. 2008) Due to its anticholinergic 
action it is sold under the name Cogentin® for the palliative treatment of Parkinson disease, as 
the imbalance between dopamine and acetylcholine can be slightly reduced. Though SERT 
affinity is low, its structural relationship to cocaine made it a candidate for further investigation. 
 
 
3.6  CFT 
 
(-)2ß-Carboxymethoxy-3ß-(4-fluorophenyl)tropane (WIN 35,428, ß-CFT) is a cocaine analogue 
with stimulating properties. Although the higher affinity and extended half-life it is not an 
explicitly restricted substance, as the synthesis is comparably difficult and involves the 
restricted intermediate ecgonine, making it highly unlikely to be used as a recreational drug. 
The main use of ß-CFT is in radiolabeled imaging studies, when cocaine itself is not convenient 
because of its inferior pharmacokinetic profile. Metabolism can be considered similar to 
cocaine, with respect to its longer half-life. Compared to cocaine, ß-CFT has higher affinity for 
both DAT and SERT, but decreased potency at the NE transporter. (Boja et al. 1992) 
3.7  CIT 
 
(-)2β-Carbomethoxy-3β-(4-iodophenyl)tropane (RTI-55, β-CIT) is another analogue of cocaine 
mainly for the use in scientific research showing highly increased potency.  By increasing the 
halogen substitution on the 4-position of the phenyl ring from fluorine to iodine SERT affinity 
was meant to be increased without affecting DAT inhibiting potency, what was successful to 
some degree. (Weed et al. 1995) Possible therapeutic use is very limited due to its high 
addictive potential. 
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4.  Computational Background 
 
In addition to the initially mentioned fact that an X-ray structure of the SERT remains missing so 
far, several other challenges already encountered in previous studies had to be faced and 
managed, as in reality both receptor and ligand are not rigid but flexible, implicating increased 
complexity of the calculations. Also, the use of different software packages often caused 
compatibility problems.  
Generally, the use of information technology in medicinal chemistry has increased nearly 
exponentially within the last decades. As the development of new drugs has become 
immensely expensive no pharmaceutical company can afford many failures, so the call for 
cheap methods to help predicting potent compounds became loud. Today the basis of 
investigations on protein-ligand interactions is prevalently a combination of software packages 
relying on a precise set of formulae describing different forces that can occur between atoms 
and molecules and, on the other hand, high-resolution structural data of the target protein, 
usually yielded from X-ray or NMR experiments. If this structural data is not available, one has 
to fall back on models. Suggestions arising out such in silico experiments can further be 
confirmed or vitiated by – mostly more expensive - in vitro or in vivo experiments. 
 
 
4.1  Molecular Modeling 
 
'A Model must be wrong, in some respects; else it would be the thing itself. The trick is to see 
where it is right' – Henry A. Bent, American chemist 
Going down to the scale of molecules or even atoms, the representation of the objects of 
interest in a conventional way like taking pictures is by far more difficult, as the wavelength of 
visible light is not quite well suited to investigate structures of – even roughly - similar scale. So 
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even if other, better applicable techniques like NMR or X-ray crystallography are used, the 
human eye needs the information to be converted to the visible optical range between 380 and 
780 nanometers, thus any effort of visualizing molecular structures must lead to one or another 
sort of a simplified model. In the history of structure determination, the huge expense of 
arithmetical calculations stood in a glaring contrast to its output of two-dimensional 
representations.  
The only true 3D alternative was the use of molecular kits like the illustrious Dreiding Models. 
To demonstrate the fussiness but nonetheless efficiency of those models one has to keep in 
mind that even Watson and Crick had to use such kits to model base pairing. During the 1970s, 
computational power became efficient enough for the first pseudo-3D visualizations of small 
molecules, further improving through the fast evolution of processors. Then, as now, to grant 
the generated structures the highest possible plausibility, the geometry always should be 
optimized to the energy minimum state, which can be done by so-called force fields. They 
consider atoms as a kind of rubber balls of different size, according to the atom type, and bonds 
as a spring-like connection of different length and angles, tending to certain standard values. 
Based on Hooke's law the overall total energy of a molecule is minimized according to the 
formula: 
 
Etot = Estr + Ebend + Etors + Evdw + Eelec + ... 
 
This describes the total energy Etot of a molecule by summing up bond-stretching energies with 
bending, torsional, van der Waals and electrostatic energy terms. (Höltje & Folkers 1996) 
Depending on the algorithm, such equations perform well on certain types of molecules, but 
may fail totally on others, as atoms have slightly different properties according to their 
molecular arrangement. 
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Force Field Small Organic 
Molecules 
Proteins Nucleic Acids Carbohydrates 
MMFF94x X   X 
AMBER99  X X  
CHARMM27  X X  
CHARMM22  X   
OPLS-AA (X) X   
Engh-Huber  X   
PEF95SAC    X 
TAFF X    
MM3* X    
Table 1: Common force fields used in commercial software packages 
 
 
4.2  Homology Modeling  
 
As brought up in the introduction, the structures of membrane-bound proteins are often not 
available due to crystallization difficulties, so it is quite common to try constructing 3D-models 
based on homologous proteins offering structures. In doing so, the primary sequence of the 
target protein has to be aligned with the sequence of the template protein. This can be done 
manually or by the software itself. If there are some unconserved regions where template and 
target vary a lot, the loops have to be sampled, i.e. predicted, by the molecular modeling 
software. The procedure of these approaches is quite well documented, but the accuracy 
always depends on the sequence homology. Typically, if the sequence identity is greater than 
50%, the model performs approximately as well as the crystal structure. Generally, more than  
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30% are said to be needed to construct reliable homology models. (Oshiro et al. 2004) Of 
course, a model built has to be carefully refined and validated to ensure the highest possible 
reliability. Concerning the geometry several parameters have to be checked. 
 
 
Figure 11: Checklist for the quality of protein models; taken from Höltje and Folkers, 1996 
 
Also the packing quality plays an important role. The tight packing of secondary structures can 
stabilize the overall stability of a protein structure, so it can be a valuable measure for the 
reliability of a model.  
 
 
Peptide bond 
planarity
Normal value = 
180° representing 
a trans 
configurated ω
angle
5% of amide 
bonds preceding 
proline residues 
occur in cis 
configuration
Cα chirality
Calculation of the 
virtual ζ torsion 
angle between 
Cα-N-C‘-Cβ atoms 
of each amino 
acid
Negative values 
signify incorrect 
D-amino acids
Bond lengths/ 
angles
Main bond 
lengths and 
angles are 
compared with 
highly resolved 
crystal structures
Deviations > 0.05 
Å or 10° are 
subject of further 
inspection
Planarity apart 
from peptide 
bonds
Aromatic amino 
acids: Phe, Tyr, 
Trp, His
Amino acids with 
sp2 hybridized 
planar end 
groups: Asn, Asp, 
Gln, Glu, Arg
  
    - 21 - 
 
  
4.3  Docking 
 
The crucial part of calculating interactions between a protein and its possible ligands is called 
the docking procedure. There are several docking tools using different algorithms, but basically 
there are three different methods: 
a) Rigid body docking: protein and ligand both are kept inflexible 
b) Semi flexible docking: rigid protein and flexible ligand 
c) Fully flexible docking: both protein and ligand are kept flexible 
There were several molecular modeling software packages available in our research group, so 
the choice had to follow the needs of the project. Here an overview over the most important 
programs available: 
Name Molecular Operating 
Environment 
Schrödinger Suite GOLD SYBYL 
Company Chemical Computing 
Group 
Schrödinger, LLC CCDC Tripos, L.P. 
Graphical User 
Interface 
MOE Maestro HERMES SYBYL 
Operating System(s) Windows, Linux (Windows), Linux Windows, 
Linux 
Linux, SGI 
Latest Released 
Version 
MOE 2008.10 Schrödinger Suite 
2009 
GOLD 4.1 SYBYL 8.1 
Molecule Building 
Module 
Yes Yes No Yes 
Ligand Flexibility Yes Yes Yes Yes 
Protein Flexibility No, Subsequent Energy 
Minimization 
Yes Limited to 10 
Side chains 
No 
(Developing) 
Table 2: Comparison of Main Software Features 
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The more flexibility is granted to the system, the more accurate results can be achieved, at the 
cost of large computational expense. A high grade of flexibility is especially useful while a 
homology model based on a low-resolution template is being used, as it is the case in this 
study, so it was advisable to follow the path of fully flexible docking. According to the needs of 
the experiments the Schrödinger software package was chosen for fitting best to the 
requirements and combined several modules that would have been needed to be taken from 
different providers, exposing the data to the omnipresent threat of compatibility problems. 
 
4.4  Scoring 
 
The results of a docking run need to be ranked in regard to their quality. Also, during a docking 
process it is useful to estimate the fitness of a ligand in the receptor during the placement 
optimization procedure.  
Usually one will try to predict the free energy of binding according to the Gibbs-Helmholtz 
equation, which can be done by applying one or more of various scoring functions, differing in 
speed and accuracy. 
 
 
 
∆G is the free energy of binding, ∆H describes the enthalpy, T stands for the temperature and 
∆S is the entropy term.  
To transform ∆G into the binding constant Ki the following equation can be used, involving the 
gas constant R: 
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There are three main approaches for scoring functions. At first the so-called Empirical Scoring 
Functions can be mentioned. They aim to calculate binding affinities by adding property terms 
known to contribute to drug binding by using multilinear regression to optimize the particular 
coefficients of the computed terms with the aid of a training set of appropriate protein-ligand 
complexes, limiting the significance of the function to structures similar to the training set. 
 
The members of the second group are called Force-field-based Scoring Functions. As the name 
implies, they are based on force fields that use molecular mechanics. Van der Waals 
interactions are expressed by a Lennard-Jones potential, electrostatic interactions are 
described by the Coulomb energy. The energy of those nonbonded interactions can be 
described by the following term: 
 
Aij and Bij describe the van der Waals repulsion and attraction of two atoms i and j at a distance 
of rij, the point charges of the atoms i and j are given by qi and qj, and the dielectric function is 
D. The factor of 332 allows the conversion of electrostatic energy to kilocalories per mole. 
As entropy contributions are not considered in force-field calculations, large and polar 
molecules tend to be scored best, which should be kept in mind when looking at the results. 
Knowledge-based Scoring Functions deny braking down protein-ligand binding energy into all 
mentionable contributions for further detailed analysis. Also, they try to avoid the threat posed 
by the limited chemical space provided by the training set in empirical scoring functions by 
using potentials of mean force. Those define the occurrence of protein-ligand atom pairs of 
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certain atom types and distances as a measure for the quality of the fit. The sum of all 
interatomic protein-ligand complex interactions results in the score.  
Still, accurate predictions of binding free energies are impossible, as some parameters as the 
role of water or exact contributions of protein flexibility remain hardly computationally 
accessible. So the focus lies on post-processing docking outputs to facilitate the job of the 
scoring functions. (Höltje & Folkers 1996) 
As an effort to improve the performance of scoring-based ligand ranking, several different 
scoring functions can be combined. There are two hypotheses why the results should improve 
by rescoring strategies. The one called 'consensus scoring' draws on the assumption that active 
compounds should be top-ranked by several scoring functions, whereas false positives should 
be reduced by fusing the data. (Charifson et al. 1999) The other strategy is to utilize the 
different strengths of scoring functions, called the complementary hypothesis, implying that the 
combined power leads to improved results. However, it can happen that one of the greatest 
benefits of rescoring, which is the reduction of computational costs for improving the results by 
several scoring algorithms that are generally faster than multiple docking procedures, gets lost 
if highly accurate but computationally expensive calculations as MMGBSA are involved. 
(O'Boyle et al. 2009) 
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5.  Materials and Methods 
 
5.1  The Model 
 
The first requirement to allow docking studies on the hSERT was the presence of a 3D structure. 
As mentioned before, an X-ray structure is not yet available, so the task was to create a 
homology model processible by well-established molecular modeling software. To be able to 
meet the demands for creating a powerful model there was an urgent need for a suitable 
template, a quite difficult task for a membrane-bound protein. 
 
5.1.1  The Template 
 
At a first glance it seems quite unlikely that the human serotonin transporter and a bacterial 
amino acid transporter have very much in common, but their structural similarity turned out to 
be a piece of luck for the modeling procedure. The availability of a crystal structure and the high 
structural similarity made the leucine transporter of the underwater bacterium Aquifex aeolicus 
(LeuTaa) the best template on-hand. Both belong to the Na
+/ Cl—dependent transporter family 
catalyzing a thermodynamically uphill carriage of their substrate. The advantage of the LeuTaa 
was its ability to form crystals, a crucial step in X-ray structure determination. The yielded 3D 
information of the protein 70Å in height and about 48Å in diameter revealed the presence of 
twelve helical transmembrane segments (TM 1-12), with both amino and carboxy termini 
looming into the cytoplasmatic side of the membrane. The protein core consists of two pseudo-
symmetric counterparts formed by TM 1-5 and TM 6-10 and is responsible for substrate and ion 
binding. This similarity cannot be seen in the primary sequence, but it is affirmed by the fact 
that the 130 α-carbons of the residues belonging to TM1-TM5 and the corresponding atoms of 
helices TM6-TM10 show a root mean standard deviation (RMSD) of just 5.3Å by a rotation of 
176.5°. (Yamashita et al. 2005) 
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5.1.2  Sequence Alignment 
 
Comparing the primary sequence of LeuT with the one of hSERT, one will just find 21% identical 
residues. The homology although can be numbered 40 to 45%. (Zhou et al. 2007) That means, 
amino acids with common properties, e.g. aliphatic residues like leucine and isoleucine or acidic 
amino acids like glutamic acid and aspartic acid, are not identical but homologue in function, so 
even with a relatively poor sequence identity of two protein sequences, their homology can be 
significantly higher. In addition, despite the problematically low overall similarity of LeuT and 
hSERT the main binding site is highly conserved, strongly suggesting a common mechanism of 
transport. In that crucial region, 19 out of 25 residues in a range of 5 Å around the centroid of 
the binding site are identical. Nonetheless, many regions remote from the direct substrate 
interaction site but important for the transporter function are quite poorly conserved and 
therefore are difficult to align. The group of Beuming et al. compared 177 eucaryotic and 167 
procaryotic NSS protein sequences to optimize those problematic regions, resulting in a 
comprehensive alignment of the LeuT with important eucaryotic members of the NSS family. 
(Beuming et al. 2006)  
  
  
    - 27 - 
 
  
 
Figure 12: Sequence alignment of LeuT with eucaryotic transporters, Beuming et al., 2006 
5.2  Schrödinger Suite 
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Having the main information needed for building the homology model at hand, still there was 
the need for a tool suitable for the actual performing of the task. The Schrödinger Suite 2008 of 
Schrödinger, LLC was chosen for several reasons. First, the embedded docking application 
allows both protein and ligand flexibility, which was mentioned before to be important for 
homology models with uncertain exact structure, second, the MAESTRO graphical user 
interface (GUI) combines most of the applications needed from the primary alignment to the 
final evaluation, which is beneficial to avoid compatibility problems that can easily occur when 
using several different software packages. 
 
5.2.1  Ligand Preparation 
 
The ligands introduced in section 3 were drawn in Maestro (Version 8.5, Schrödinger, LLC, New 
York, NY, 2008) according to the structural information yielded from Chemical Abstracts Service 
(CAS) via SciFinder (Chemical Abstracts Service, Brandywine, MD, 2007). If due to chiral centers 
more stereoisomers were available, the most active described in literature was chosen. The 
generated ligand library was adapted to physiological state, e.g. the primary amine of serotonin 
was protonated as it would be under binding conditions. The further energy minimization was 
performed using the OPLS force field. 
 
5.2.2  Prime Structure Prediction 
 
For the actual building of the homology model the Prime structure prediction application 
needed the input of the primary sequence of hSERT. For this purpose the SWISSPROT/Expasy 
site (www.expasy.org/sprot, now www.uniprot.org) delivered the essential information under 
the access number P31645 (SLC6A4_HUMAN). The 630 amino acid long sequence was saved in 
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the FASTA file format containing also information about the species and the protein family, and 
used as a query input for Prime. Out of several LeuT template structures with similar resolution 
that were found the crystal structure with the PDB code 2QB4 was chosen, also offering the co-
bound substrate leucine, the antidepressant desipramine and two sodium ions in the inner 
binding site. For the proper use as a template, the protein was refined using the Protein 
Preparation Wizard that deleted needless water and solvent molecules. Furthermore, the 
residues Asn133 and Ala134 missing in all available LeuT X-ray structures had to be added in 
order to close the gap between Pro132 and Thr135. Although the loop region containing the 
gap is not supposed to be important for ligand binding the missing residues had to be replaced 
to facilitate an energetically stable template structure. To do so, the sequence of the pdb file 
was aligned with its own but complete primary sequence again obtained from the SWISSPROT 
site using the Prime structure prediction module. 
  
 
Figure 13: Comparison of EL 1 in 2A65 (red)  and 2QB4 (blue) based models 
 
The processed, so to say repaired LeuT structure now was able to serve as a proper template 
for creating the SERT model. According to the prior alignment scheme of Beuming et al. the two 
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sequences were manually aligned, allowing the sequence of the hSERT to adapt to the 3D 
structure of the 519 residue-long procaryotic relative. Some loops in unconserved regions of 
the protein needed to be built and/or fixed, like a disulfide bond between Cys200 and Cys209 
formed using a detection tool downloaded in the Schrödinger Script Center.  
 
After the compulsory energy minimizing step the model was checked against SERT models 
previously built in our group and by the group of Celik et al., based on LeuT structure entry 
2A65. The overall RMSD value of 4.17 Å between the different models was comparably high 
resulting from differences mainly in the larger extracellular loop regions. For example, the 60 
residues between TM3 and TM4 are extremely flexible, though the cystine moiety suggested in 
the topology diagram of Rudnick (Gary Rudnick 2006) also detected in the newly built model 
seemed to slightly stabilize the internal structure of the loop. 
 
 
Figure 14: Inner binding site 
 
Nevertheless the region is not of direct interest for substrate binding, so even major deviations 
do not pose a problem for the equivalence of different models. The considerably low RMSD 
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value of 0.43 Å concerning the residues forming the binding site stands in contrast to the higher 
values in the peripheral regions, thus granting comparable results.  
 
 
Figure 15: RMSD values of different SERT models 
  
 
5.2.3  PrimeGlide Induced Fit Docking 
 
The main difference between standard GLIDE docking and the Induced Fit Docking workflow is, 
as mentioned before, the protein flexibility apart from normal energy minimizing steps used by 
nearly any docking software. That means, in principle every ligand pose has its corresponding 
receptor with a unique structure, making the data processing especially challenging. For the 
generation of the receptor grid either the centroid of an already placed ligand or the centroid of 
defined residues were selectable. It turned out that the best choice were the residues forming 
the inner binding site. 
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Table 3: Localization of the residues forming the inner binding site 
As the template structure represented the occluded state of the transporter, the space for the 
ligand placement inside the binding site was rather limited, so the side chains of the aromatic 
residues were initially removed to be rebuilt after the primary placement. As major influence of 
forces outside the protein could be excluded due to the occluded nature of the model the use 
of an implicit membrane meaning huge computational expenses could be omitted. With the 
selection of the desired precision mode responsible for the calculation time (Standard 
Precision/SP or Extra Precision/XP mode) and the definition of the prior generated ligand library 
the job was ready to be started. 
Figure 16: General workflow 
 
•Box center 
definition
•Box size 
definition
Glide Grid 
Setup
•Input of the 
ligand library
Ligand 
Definition •Selection of 
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initially removed
•Definition of van 
der Waals scales
Initial Glide 
Docking
•Defining the area 
kept flexible
•Selection of 
membrane options
Prime Induced 
Fit •Setting up the 
precision mode
•Selection of 
redocking criteria
Glide 
Redocking
Localizatio
n 
Residues 
TM 1 Tyr95, Asp98 
TM 3 Ala169, Ile172, Ala173, 
Tyr176 
TM 6 Phe335, Ser336, Phe341 
TM 8 Ser438, Thr439, Gly442 
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5.3   Data Processing 
 
The large amounts of data generated during a docking experiment have to be screened for their 
essential information prior to being able to speak of results. The data analysis was supported by 
several computational tools available for sorting and assessing the output files. 
 
 
5.3.1  IFDScore 
 
Looking at the output files created during the docking process, 49 different weighting and 
energy contribution values for each pose were offered. After all, the poses were by default 
ranked according to the IFDScore value, a virtual binding free energy term. The composite score 
consists of GlideScore, standing for protein-ligand interaction energy, and a 5% admixture of 
PrimeEnergy, the protein molecular mechanics energy term. It was developed to eliminate 
predicted structures with an energy gap large enough compared to the lowest PrimeEnergy 
value to be considered noise. 
 
5.3.2 Clustering 
 
 
To fetch also sterical information the poses had to undergo a hierarchical clustering procedure 
by operating the embedded XCluster application. The module embedded in the Schrodinger 
software package allows several modes of hierarchical clustering.  
The sterical pose features are compared either superposed or in place, according to RMSD 
values or clustering levels corresponding to the number of different docking poses.  
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The application also offers a graphic for a quick overview over the clustering behavior of the 
members of a docking run, so called clustering statistics. Depending on the chosen RMSD or 
clustering level value the thresholds for a cluster membership differ, modifying the cluster sizes. 
In most cases it is useful to visualize the calculated clusters for final judgment of the 
determination quality of the chosen clustering mode. 
 
Figure 17: Clustering statistics for a docking run with serotonin 
The figure above plots the clustering level against the cluster sizes, each level standing for a 
pose assigned to a cluster aggregation step. The faster the cluster size increases, the more 
similar are its members. Several other visualization modes exist that can be applied to judge the 
clustering behavior depending on the respective requirements. In the results section the 
clustering value is plotted against the cluster sizes, clearly showing the threshold value for the 
first cluster to form. 
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5.3.3  MM-GBSA Rescoring 
 
Although the internal IFDScore seemed to be quite reliable for reasonable ligand ranking, it was 
desirable to introduce an external ranking tool, which was found in the MM-GBSA rescoring 
application. This post docking scoring protocol had proved its ability to correctly rank a series of 
kinase inhibitors, so it was chosen for the experiment. (Lyne et al. 2006) It turned out that the 
program was designed for rescoring docking results of Schrödinger's Glide application with a 
single protein input file and a ligand pose library, but it was not able to handle target proteins 
with slightly changing binding pockets as produced by induced fit docking runs. As the main task 
of the rescoring procedure was considered the confirmation of the overall IFDScore ligand 
ranking and not weighting the different ligand poses, the most reasonable way to handle the 
challenge was to take the best scored pose complex of each ligand and re-divide it into protein 
and ligand. Stored as separate files the data could be taken as input for the rescoring tool. 
The X-Score program obtained from Dr. Renxiao Wang from the University of Michigan was 
planned to be used as a third, also external, rescoring tool, but failed due to compatibility 
problems. 
 
5.4  Validation of the Method 
 
The fact that the template structure was published with a co-crystallized substrate bound to the 
binding site offered a good possibility to prove the ability of the method to retrieve valid 
binding modes, while it has to be kept in mind that due to the nature of crystallizing procedures 
the states showed by X-ray structures do not necessarily need to represent the actual in-vivo 
binding mode. 
During the first step, the raw pdb file downloaded from the Protein Data Base (PDB) had to be 
processed for the further use as a docking target structure. This was done by the Protein 
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Preparation Wizard, capable of adding missing hydrogen atoms, removing co-crystallized 
solvent or simple water molecules and categorizing missing atom types. The latter is necessary 
because sometimes some of the residues are not fully recognized due to the fact that during 
the X-ray structure determination nitrogen and oxygen atoms are just categorized by their 
position in the particular amino acid, as the electron densities of the two atom types are 
similar. 
After that procedure, the protein complex consisted just of the 516 residue-long chain, two 
sodium ions and still the bound substrate. This leucine was subject to further deletion, to offer 
a free binding site for its re-docking. Applying similar settings also used for the actual 
experiments the program was offered the isolated leucine structure as the ligand file to be 
docked into the empty LeuT binding site consisting of the residues corresponding to those in 
the hSERT. Out of initially sixteen valid poses from the primary docking stage, eight successfully 
passed the sorting and filtering steps to the scoring stage, taking an overall of 6774 seconds 
equal to two hours calculation time in standard precision mode.  Compared with the crystal 
structure, the best-ranked docking pose showed an overall RMSD of 0.47 Å respectively 0.24 Å 
in crucial binding areas. (Fig.13) Also the standard clustering procedure included the best-
ranked pose in the top cluster, showing that both methods have a reasonable informative 
value.  
 
Figure 18: Original and best-ranked docking pose of leucine in LeuT 
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6.  Results  
 
After a series of test runs to determine the optimal calculation settings the main docking runs in 
standard and extra precision mode were set up. Compared to the redocking procedure for the 
validation experiment, the time consumption of the main calculations was by far higher, taking 
138 hours for the SP and 136 hours in XP mode. Also, on first sight it might seem strange that 
the more precise mode took less time, but taking into account that the SP docking run had to 
deal with 493 valid initial docking poses and an overall final output of 126 unique structure files, 
the 107 final pose files of the XP run resulted out of initially 478 valid poses. That means an 
overall of 66 minutes per final pose in SP mode compared to 76 minutes in XP mode or an 
increase of 15% of average calculation time for the more precise experiments. In general, 
results yielded in XP mode were considered to be more precise, so the results section refers to 
SP results just in case that further information gain could be achieved by their detailed 
examination. 
 SP XP 
Initial Poses 493 478 
Final Poses 126 107 
Total Time (min.) 8307,5 8181,1 
   
Time per initial pose 16,9 17,1 
Time per final pose 65,9 76,5 
Time per overall pose 13,4 14,0 
Table 4: Docking time validation 
 
The distribution of poses per ligand was similar for both precision modes, as it can be seen in 
the following table.  
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As the score of each pose was broken down into several energy contribution values, during the 
further steps a large amount of data had to be processed. By default, the primary ranking was 
not according to the ligand type but to the IFD Score value. Henceforward the ligands had to be 
moved into separate groups to be made comparable for the clustering tools. For the selection 
of the favored poses we decided to combine different criteria to be met. The best-ranked 
complex for each ligand was automatically taken as a result due to the significance of the 
parameter already proven during the redocking process. In addition, the in-place clustering 
behavior at dedicated RMSD thresholds of 1.5, 2.0 and 2.5 Å was examined in case that the 
primary population was large enough to suggest possible information gain. 
 
Figure 19: Pose Selection Parameters 
 
Pose 
Selection
Top IFD Score
Leading Member of 
Highly Populated 
Cluster
Unique Interaction 
Mode of a Ligand 
with Low Overall 
Contribution to the 
Population
Standard Precision (SP) Mode:
•Serotonin ∑= 58 poses
•Cocain ∑= 16 poses
•Methylphenidate ∑= 19 poses
•MDMA ∑= 26 poses
•ß-CFT ∑= 1  pose
•ß-CIT ∑= 1  pose
•Benzatropine ∑= 5  poses
Extra Precision (XP) Mode:
•Serotonin ∑= 37 poses
•Cocain ∑= 12 poses
•Methylphenidate ∑= 23 poses
•MDMA ∑= 28 poses
•ß-CFT ∑= 2   poses
•ß-CIT ∑= 2   poses
•Benzatropine ∑= 3   poses
Table 5: Pose numbers 
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The resulting files created out of the best-ranked pose for each ligand were also re-divided into 
separate protein and ligand files for the MM-GBSA rescoring step, leading to the following 
primary ligand ranking. 
 
Compound Acronym IFD Score MMGBSA 
L/R ligand 
energy 
MMGBSA 
Complex 
Energy 
Serotonin 5-HT -855.06 -65.74 -16.91 
Methylenedioxymethamphetamine MDMA -854.40 -11.54 -16.86 
Methylphenidate MPD -850.22 -9.31 -16.83 
Benzatropine BTP -845.38 37.95 -16.76 
Cocaine COC -844.84 27.83 -16.81 
2β-Carbomethoxy-3β-(4-
fluorophenyl)tropane 
CFT -841.62 19.84 -16.79 
2ß-Carbomethoxy-3ß-(4-
iodophenyl)tropane 
CIT -836.80 19.02 -16.78 
Table 6: IFDScores correlated to MM/GBSA Energies, r²=0.71, without BTP:r²= 0.86 
6.1  Serotonin 
 
The natural ligand did not just produce the most final poses, it also achieved the best overall 
scores. The 37 XP poses seemed perfect for applying the different pose selection tools, as they 
were structurally diverse but yet able to form clusters at the chosen RMSD thresholds. 
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For the clustering level corresponding to the 1.5 Å thresholds still six clusters with more than 
one member were calculated, but going up to 2.0 and 2.5 Å the poses merged to four and 
finally two clusters, each with the best-ranked pose as the leading pose in the highest 
populated cluster. 
 
 
Figure 20: Clustering Statistics for Serotonin 
 
Exhaustive investigation on the protein-ligand interactions of the best-ranked pose showed an 
interaction pattern similar already published data. (Celik et al. 2008)  
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Figure 21: 5-HT interactions of the best-ranked pose and pose taken from Celik et al., 2007 
 
A common feature of most ligands binding to the SERT is the salt bridge between the positively 
charged nitrogen and the aspartic acid Asp98. As a second anchor point serves the hydroxy 
group in position 5 of the ligand, respectively the side chains of Ser438 and Thr439, joined by 
hydrogen bonding. The pi-pi interaction of Tyr 176 with the phenyl ring of serotonin 
questionable, as only molecular dynamics simulations would be able to show the stability of 
this interaction 
 
 
Figure 22: Comparison of MOE  and Schrödinger output leading poses 
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Also the comparison with the leading pose yielded in earlier rigid docking experiments with the 
MOE program package (dark blue) showed a similar orientation. 
 
Figure 23: Orientation of Serotonin Poses around Asp98 
6.2  MDMA 
 
The internal scoring application ranked several MDMA poses higher than less favorable 
serotonin results, consistent to published affinity data. (Rothman & Baumann 2003) Taking a 
look on the clustering behavior of the MDMA poses, two main clusters became apparent with 
the two best-scored poses as the respective leading members. The figure on the right shows 
the output data for the clustering levels corresponding to the 2.0 and 2.5 Å thresholds. Looking 
at an overlay of the Cluster 1 members it was remarkable that they arranged themselves like 
snapshots of a movement through the final part of the ligand channel down into the final 
position inside the binding site, naturally within the comparably narrow limits of the defined 
receptor grid. 
 
Figure 24: Leading Position of Poses 1 and 2 
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Figure 25: Superposition of MDMA Cluster 1 
 
 
 
Taking the best ranked pose, at the same time the leading pose of cluster 1, the main binding 
interactions with the protein are the previously mentioned salt bridge with the aspartic acid 98 
and a backbone interaction with Phe 335, supplemented by a good steric fit. 
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Figure 26: Interactions of the two best-ranked MDMA poses 
The second pose cluster is turned by an angle of about 90° compared to the first one, sharing 
the positively charged nitrogen as the center of rotation. This causes the common side chain 
interactions with D98 and F335. Additional features can be seen regarding the two ether 
oxygen atoms with R104 respectively Y175 and an arene-cation interaction of F341 with once 
again the positive charge of the ligand nitrogen. 
 
Figure 27: Superposition of pose 1 with rigid docking leading pose 
 
Comparing the top pose of cluster 1 to the leading pose of the rigid docking experiments, again 
a similar binding mode could be observed. For better orientation, Asp98 is also being displayed 
in the figure above. 
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Figure 28: Position of the Leading Poses in the Binding Site 
As it can be seen in the distance map of the XCluster module, the first cluster was formed at a 
0.46 Å threshold, similar to serotonin. Nevertheless, the clear differentiation of the MDMA 
poses into two large clusters within a narrow distance range stands in contrast to the 
comparably late main cluster formation of serotonin, as the high structural diversity of 
serotonin poses is reflected in the comparison of the two distance maps. 
        
Figure 29: MDMA (left) and Serotonin (right) pose distance maps 
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6.3  Methylphenidate 
 
This ligand takes an exceptional position within the tested substances. As in some studies no in-
vitro binding to SERT could be detected for this drug (Markowitz et al. 2006), others show at 
least about 2000-fold reduced inhibition potency of methylphenidate compared to DAT or NET. 
(Han & Gu 2006) However well-ranked docking poses were generated. Therefore, these 
structures were considered artifacts and might support the theory that ligand specificity is at 
least partially accomplished by regions outside the binding site as for instance the substrate 
channel. Further considerations about the kinetics of binding were suspended to later on 
studies, carrying forward the previous workflow.  Once again, the clustering visualization tools 
showed the clearly favored orientation in the binding site dictated by the best-ranked pose as 
leading member of cluster 1, at which 13 of 23 poses belong to the highest populated cluster at 
the 2.5 Å threshold. The second largest cluster with four members led by pose 9 formed at the 
2.0 Å threshold. As it can be seen in the figure below, the large cluster formed quite below the 
first critical value of 1.5 Å. 
     
Figure 30: Formation of Methylphenidate Cluster 1 
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Comparing the two leading members with those of the top MDMA clusters, the similar 
orientation of the ligands was quite remarkable. 
 
Figure 31: Overlay of leading MDMA and MPD poses 
Looking at the best-ranked methylphenidate pose, an interaction pattern similar to the 
previous compounds arises. Along with the ionic bond affecting D98 and its nitrogen 
counterpart, again a backbone interaction with F335 and an additional π-π interaction with 
Y176 could be found. 
 
Figure 32: Best calculated methylphenidate interactions 
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Leading member of cluster 2, the second chosen methylphenidate structure, showed the well-
known interaction with D98 and another side chain interaction with Y95. 
 
6.4  Benzatropine 
 
The first member of the docked tropane derivatives yielded just three valid poses, two of them 
sharing the same orientation with an RMSD value of just 1.25 Å. 
 
Figure 33: Benzatropine distance map 
 
The IFD-Scores were relatively poor, taking the ranks 90 to 92 out of 107 poses. As it is 
mentioned later in the cocaine section, this can be subject to the relatively narrow borders of 
the binding site that were defined according to the corresponding substrate binding site in the 
LeuT. A recently published paper, though being concerned with the DAT, strongly suggests a 
tropane binding pocket slightly shifted to the extracellular part of the protein. (Huang et al. 
2009) 
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Figure 34: Superposed Benzatropine Poses (Discarded Pose in Red) 
 
 As the medium-ranked separate pose did not share its orientation with any of the other main 
tropane derivatives the population of Benzatropine poses was increased by the SP output data, 
adding five Benzatropine structures for further investigation. Within the SP population, the BTP 
poses were even worse ranked, but all of them shared the main XP orientation, leading to the 
assumption that the second XP pose could be considered an outlier.  
 
The main conformation showed the central D98-interaction and a π-π interaction with W103. 
Interesting about the latter is the fact that the tryptophan at this position is conserved within 
the main eucaryotic monoamine transporters that usually have binding affinities in the same 
orders of magnitudes for tropane-like transporter inhibitors. 
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Figure 35: Best-ranked Benzatropine interactions with the hSERT 
 
During the MM-GBSA rescoring step Benzatropine was the only ligand with an overall ranking 
not consistent with the IFD Score results. Though the leading pose was the best ranked tropane 
structure according to its IFD score value, it obtained the lowest MM-GBSA score within all 
tested ligands, yet another reason for further experiments with an expanded binding site. 
 
Figure 36: Residues Involved in Benzatropine Binding 
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6.5  Cocaine 
 
The total amount of six poses with totally different interaction patterns in the output of this 
ligand made a clustering step useless. In the figure below the overlay of the poses shows the 
different orientations of the molecule, highlighted by the special representation of the nitrogen 
atoms.  
 
Figure 37: Superposed cocaine poses 
To be consistent with the general workflow the clustering module was applied anyway, also to 
prove the ability to detect poor clustering behavior of a population. To do so, the clustering 
statistics were examined. 
 
Figure 38: Distance Map of the Cocaine Poses 
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The figure above shows the distance map for cocaine at a clustering level of 2, revealing a 
threshold distance of 4.9 Å necessary to form the first cluster.  
In addition to the scoring value it seemed reasonable to consider the position of the 
subsequently discussed cocaine analogues that yielded even less poses, apparently due to their 
bulky halogen moiety. An overlay of the cocaine poses with the results for ß-CFT showed that 
the binding mode of the best-scored cocaine pose was consistent with the cocaine analogue. 
       
Figure 39: Overlay of cocaine and ß-CFT 
As the comparably few interactions of the leading cocaine pose consisting of just a π-π 
interaction with F341 and the steric fit inside the pocket are also not reproducible within the 
other poses the result is quite questionable. A paper recently published discussed the 
interactions of cocaine and its analogues with the dopamine transporter, where it was shown 
that an interaction of the positively charged nitrogen with D79 in DAT, the conserved amino 
acid corresponding to D98 in the SERT, is very likely to exist. F326, the residue corresponding to 
F341, is mentioned in the paper, but not as an essential residue. (Beuming et al. 2008) The 
recent work of Huang et al. even proposes that the binding site of cocaine and its analogues is 
about 11 Å above the current one, though the paper also just refers to the DAT. 
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Figure 40: Proposed cocaine interactions 
 
6.6  ß-CFT 
 
This halogen-substituted cocaine analogue with highly increased potency produced just two 
valid poses quite similar to each other in the extra precision mode. Additional data from the SP 
run was consistent with the XP poses with an RMSD of below 2 Å. 
 
Figure 41: CFT Poses of the XP Run and Additional SP CFT Pose (Orange) in Superposition 
 
  
    - 54 - 
 
  
 
The rank of the ligand at the lower end of the pose population both in IFD and MM-GBSA score 
was not very surprising at first sight, as a certain preference for DAT binding has been observed 
for the compound. Although an earlier in-vitro assay in rat tissue found the compound to be an 
even more potent SERT uptake inhibitor than cocaine with IC50 values of 91.0 nM vs. 260 nM 
(Kuhar et al. 1999), recent studies in human embryonic kidney cells (HEK 293) showed that CFT 
has –apart from its unquestioned higher DAT potency- a SERT binding and transport inhibition 
IC50 of 2300 nM (±0.3), therefore about 3-4 fold higher than cocaine with an IC50 of about 580 
nM (±110), justifying the CFT scores being lower than the cocaine values. (Riss et al. 2009) 
Investigations on the leading pose showed just a π-π interaction with Y176. Earlier binding 
studies for this substance on the DAT would lead to the assumption that D98 is involved in the 
binding, but the 6.3 Å distance between the negatively charged residue and the quaternary 
nitrogen atom makes this interaction highly unlikely.  
 
 
Figure 42: Computationally preferred ß-CFT binding pattern 
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6.7 ß-CIT 
 
Again, the yield of poses with a total of two output structures was quite poor. Even looking at 
the results from the SP mode just one additional structure was available, not only the worst 
ranked of all poses but also similar to one pose already available in the XP data, so its 
consideration was needless. The overall orientation of the primary pose was similar to the one 
of ß-CFT, but it did no longer show the π stacking with Y176 known from the previous ligand. 
 
      
Figure 43: ß-CIT in the binding pocket and in superposition with ß-CFT 
 
Taking a look at the second calculated binding mode, the interaction pattern looks different, as 
the ligand is nearly 180° turned in the pocket, and now shows not only the ionic interaction 
with D98, but also a backbone interaction with F335 and an arene-cation bond between F341 
and the positively charged nitrogen, a pattern quite familiar from non-tropane ligands. 
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Figure 44: Secondary binding mode of ß-CIT 
The reason for that prima facie better pose to be less favorable for the scoring function lies in 
several energy contributions, as it can be seen in a variety of scores below. 
 
 
Figure 45: Different energy contributions for CIT poses 
 
Anyway, the differences in the IFD score were minimal with -836.8 vs. -836.3.  
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Figure 46: Antipodal Orientation of ß-CFT Poses 
   
Although the only difference to the previous compound is the fluorine substituted by iodine, 
the change in the experimental values is huge. Still being predominantly DAT selective (IC50 
=6.34±1.68 nM), the SERT potency (IC50 =29.17 ± 6.40 nM) is a lot higher than the one of 
cocaine (IC50 =580.73 ± 113.16 nM). (Okada et al. 1998) Once again it is tempting to doubt 
either the method or the positioning of the binding site, as the calculated data is not quite 
consistent with the experimental data. In any case further experiments with an expanded 
binding site seem inevitable. 
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7. Discussion and Outlook  
 
Although we are still bound to the limitations of a model, the method showed to be quite 
accurate and fast applicable. Compared to earlier experiments keeping the protein backbone 
rigid the low number of output poses was surprising. An overlay of the poses yielded showed 
that the theoretical framework of induced fit backbone movements was not exploited; anyway, 
subsequent global energy minimization steps could be omitted due to the program architecture 
performing in-process minimization. Structures resulting from rigid-docking experiments in our 
group were available for five of the seven ligands. Comparing the final poses with those yielded 
in the previous work, the central interactions could be observed for most ligands except the 
tropane derivatives. As mentioned in the respective results section, this fact can be due to a 
possible shifted binding site for this group of ligands or actually a unique binding mode, calling 
for further investigation. The correlation of scoring values to in-vitro affinity data was especially 
challenging due to inhomogeneous cell systems. It is not surprising that rat tissue yields 
different data compared to, for instance, HEK cells, but several ligands simply could not be 
measured in identical test systems. As affinity fluctuations added up to several orders of 
magnitude for a single ligand, depending on the cell system, correlating scoring data to IC50 
values was abandoned. Questions emerging out of these results will need further investigation 
both in careful watch of newly released literature and furthermore continuative experiments. 
Shifted or expanded binding sites will play an important role as well as the use of additional 
software modules and further model refinement. Maybe the largest information gain will result 
out of experiments using molecular dynamics (MD) simulations, promising to identify stable 
ligand orientations, but yet limited due to the immense use of computational power needed for 
MD calculations. Definitely, docking algorithms keeping the binding site flexible stand for an 
important improvement in the method per se, yielding structures that can be used as good 
binding mode suggestions for new ligands and as starting structures for MD simulations. The 
Induced Fit protocol led to a significantly lower number of output poses, yet keeping behind the 
expectations in actual side chain and backbone movements. As far as it can be judged by 
hitherto yielded data, the results seem reliable. Still the data processing is difficult due to the 
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fact that many applications can not deal with a series of ligand-protein complexes with 
changing protein backbone. However, as it becomes more and more common to keep both 
ligand and protein flexible it will be just a matter of time until most software modules can 
handle Induced Fit output data.  
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Abstract 
 
The selective reuptake of serotonin (5-hydroxytryptamine, 5-HT) from the synaptic cleft back into the 
nerve cell is performed by the presynaptic membrane-embedded serotonin transporter (SERT), thus 
terminating neurotransmission. An experimentally resolved structure of the SERT was not yet published, 
but the determination of binding mode hypotheses between ligands and a protein binding site with 
missing high-resolution structural data could be realized by creating a homology model of the protein of 
interest. As the SERT belongs to the neurotransmitter sodium symporter (NSS) or solute carrier 6 family 
(SLC6), its sequence could be aligned with a bacterial analogue, the prokaryotic leucine transporter 
LeuT. A detailed alignment of the SERT with the LeuT (PDB Code 2QB4) is available. Despite relatively 
poor sequence identity, it offers a highly conserved binding site, making homology modeling possible. 
For obtaining accurate information on binding interactions, flexibility both of ligand and target had to be 
taken into account, as it was done by a recently introduced efficient docking method, called Induced Fit 
Docking. The software necessary for applying the method was embedded in the Schrödinger molecular 
modeling software package by Schrödinger, LLC. It granted the binding site more flexibility than other 
docking programs and allowed to perform most of the working steps from the drawing of the ligands to 
the final evaluation steps within one software package. The ligand library consisting of the natural ligand 
serotonin and a selection of drugs that are known to bind into the SERT was docked into the inner 
serotonin binding site. After the final homology model had been created and the correct parameter 
settings were identified the docking experiments in two precision modes were performed. The output 
data was sorted according to calculated energy values and examined for its clustering behavior, leading 
to the selection of favored poses and therefore interaction pattern suggestions. The significance of the 
results was strived to be assured by several validation steps. The method itself proved its ability to 
retrieve experimentally resolved binding modes in a re-docking experiment with the template protein-
ligand complex. For the docking experiments the selected binding modes were compared with published 
data. The results for serotonin were consistent with the data available, indicating similar quality for the 
ligands which yet lack information about their binding mode. The compounds based on the tropane 
scaffold were docked in a mode different from all other compounds, which needs further evaluation. 
However, as far as it can be judged by hitherto yielded data, the results seem reliable, and it will be just 
a matter of time until Induced Fit docking is implemented in most software modules.  
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Zusammenfassung 
 
Die selektive Wiederaufnahme von Serotonin (5-Hydroxytryptamin, 5-HT) aus dem synaptischen Spalt 
erfolgt durch den präsynaptischen membrangebundenen Serotonintransporter (SERT), was zur 
Beendigung der Neurotransmission führt. Bisher wurde noch keine experimentell ermittelte 3D-Struktur 
des SERT publiziert, trotzdem können Studien über den Bindungsmodus zwischen Liganden und ihren 
korrespondierenden Bindungsstellen in diesem Protein realisiert werden, indem man ein 
Homologiemodell erstellt. Da der SERT zur Neurotransmitter-Natrium Symporter (NSS) oder Solute 
Carrier 6 (SLC 6) Familie gehört, kann seine Primärsequenz mit jener eines bakteriellen Analogons (LeuT, 
PDB Code 2QB4) übereinandergelegt werden, wofür bereits ein detaillierter Plan publiziert wurde. Trotz 
der verhältnismäßig geringen Sequenzidentität bietet das Protein eine gut konservierte Bindungstasche, 
was das Generieren eines Homologiemodells möglich macht. Um genaue Informationen über 
Bindungsmodi zu erhalten, muss die Flexibilität sowohl des Liganden als auch des Zielproteins 
berücksichtigt werden, so wie es bei einer kürzlich vorgestellten effizienten Docking Methode namens 
'Induced Fit Docking' der Fall ist. Die dazu benötigte Software ist in das Schrödinger Suite 
Programmpaket von Schrödinger, LLC eingebettet. Die Ligandenbibliothek bestand aus dem natürlichen 
Substrat Serotonin sowie einer Auswahl von Verbindungen mit Affinität zum SERT. Nach der 
Fertigstellung des Homologiemodells und dem Erarbeiten der korrekten Parameter wurden die Docking 
Experimente in der inneren Bindungstasche des Proteins in zwei unterschiedlichen Präzisionsmodi 
durchgeführt.  Die dabei erzeugten Daten wurden nach Bindungsenergie und ihrem  Clusterverhalten 
sortiert, was zur Auswahl favorisierter Posen und verschiedenen Vorschlägen möglicher 
Interaktionsmuster führte. Dabei wurde versucht, die Signifikanz der Ergebnisse durch mehrere 
Validierungsschritte sicherzustellen. Die Fähigkeit der Methode zum Wiederauffinden experimentell 
ermittelter Bindungsdaten zeigte sich in einer Redocking Prozedur, bei den Experimenten wurden die 
ausgewählten Bindungsmuster mit der Literatur verglichen. Die Ergebnisse für Serotonin waren 
konsistent mit publizierten Daten, was eine ähnliche Qualität für Liganden mit bisher unbekanntem 
genauen Bindungsmodus verspricht. Die Substanzklasse der Tropanderivate erwies sich als 
problematisch und bedarf weiterer Untersuchungen. Dennoch scheinen die Ergebnisse, soweit man es 
bis jetzt beurteilen kann, verläßlich zu sein, und es dürfte nur eine Frage der Zeit sein, bis Induced Fit 
Docking in den meisten Softwarepaketen implementiert sein wird. 
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